Brad Bernstein

Called SETDB1, the protein could one day be targeted by new drugs for cancer patients who don’t respond to existing immunotherapies.

A better understanding of these changes could one day point to new ways to stop cancer.

Genetic insights about autism spectrum disorder and insomnia, first cellular atlas of the primate retina, and more.

Single-cell genomics study reveals cell types relevant to disease progression, immune response suppression.

In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

By mapping gene expression at the single cell level, researchers find that a unique transition may assist the spread of head and neck tumors.